These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22517200)

  • 1. The philosophy of treatment of uveitis: past, present and future.
    Kruh J; Foster CS
    Dev Ophthalmol; 2012; 51():1-6. PubMed ID: 22517200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.
    Foster CS; Kothari S; Anesi SD; Vitale AT; Chu D; Metzinger JL; Cerón O
    Surv Ophthalmol; 2016; 61(1):1-17. PubMed ID: 26164736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of uveitis.
    Lee FF; Foster CS
    Expert Opin Pharmacother; 2010 May; 11(7):1135-46. PubMed ID: 20367272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid-sparing agents: conventional systemic immunosuppressants.
    Kruh J; Foster CS
    Dev Ophthalmol; 2012; 51():29-46. PubMed ID: 22517202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Road to remission: a comprehensive review of therapy in uveitis.
    Siddique SS; Shah R; Suelves AM; Foster CS
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1497-515. PubMed ID: 21936708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapeutic approaches in ocular inflammatory diseases.
    Kurup SK; Chan CC
    Arch Immunol Ther Exp (Warsz); 2005; 53(6):484-96. PubMed ID: 16407781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side-effects of anti-inflammatory therapy in uveitis.
    Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
    Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in corticosteroid therapy for uveitis.
    Taylor SR; Isa H; Joshi L; Lightman S
    Ophthalmologica; 2010; 224 Suppl 1():46-53. PubMed ID: 20714181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment options for noninfectious uveitis.
    Gomes Bittencourt M; Sepah YJ; Do DV; Agbedia O; Akhtar A; Liu H; Akhlaq A; Annam R; Ibrahim M; Nguyen QD
    Dev Ophthalmol; 2012; 51():134-61. PubMed ID: 22517211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Options and strategy for the treatment of chronic endogenous uveitis].
    Garweg JG
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):367-72. PubMed ID: 17458817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory Therapy in Uveitis.
    Tomkins-Netzer O; Talat L; Ismetova F; Samy A; Lightman S
    Dev Ophthalmol; 2016; 55():265-75. PubMed ID: 26501368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.
    Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
    Expert Opin Pharmacother; 2014 Oct; 15(15):2141-54. PubMed ID: 25226529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid-sparing agents: new treatment options.
    Tomkins-Netzer O; Taylor SR; Lightman S
    Dev Ophthalmol; 2012; 51():47-56. PubMed ID: 22517203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospects of immunotropic therapy of traumatic uveitis].
    Valeeva RG; Grishina VS; Iluridze SL; Isaeva RT
    Vestn Oftalmol; 1998; 114(4):26-8. PubMed ID: 9771084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive agents and nonsteroidal anti-inflammatory drugs for ocular immune and inflammatory disorders.
    Hemady RK; Chan AS; Nguyen AT
    Ophthalmol Clin North Am; 2005 Dec; 18(4):511-28, vi. PubMed ID: 16314216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission.
    Netzer P; Gschossmann JM; Straumann A; Sendensky A; Weimann R; Schoepfer AM
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):865-9. PubMed ID: 17873610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uveitis: advances in understanding of pathogenesis and treatment.
    Read RW
    Curr Rheumatol Rep; 2006 Aug; 8(4):260-6. PubMed ID: 16839504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapies in development for the management of non-infectious uveitis: A review.
    Hassan M; Karkhur S; Bae JH; Halim MS; Ormaechea MS; Onghanseng N; Nguyen NV; Afridi R; Sepah YJ; Do DV; Nguyen QD
    Clin Exp Ophthalmol; 2019 Apr; 47(3):396-417. PubMed ID: 30938012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.